The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancer
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (11) , 1513-1518
- https://doi.org/10.1016/0959-8049(93)90285-n
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial.Journal of Clinical Oncology, 1990
- Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancerBreast Cancer Research and Treatment, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Prednisolone improves the response to primary endocrine treatment for advanced breast cancerBritish Journal of Cancer, 1988
- Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081Cancer, 1988
- Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapyCancer, 1986
- CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST CANCERThe Lancet, 1984
- Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapyCancer, 1983
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977